viewRedfund Capital Corp.

Redfund Capital reckons portfolio firm Biolog Inc is "on the cusp" of greatness

Biolog's technology is protected by multiple patents, including a patent portfolio licensed from Lexaria

Biolog Inc is a cannabis infusion firm

Redfund Capital Corp (CSE:LOAN) says investee firm Biolog Inc is on the "cusp of greatness" as it outlined the progress of the Silicon Valley and  LA-based cannabis infusion specialist.

In August, Redfund and Biolog signed a two-year term convertible secured promissory note for $800,000 with an annual interest rate of 14%.

Biolog's technology is protected by multiple patents, including a patent portfolio licensed from Lexaria.

This allows the dosing of almost any food or beverage with either cannabidiol (CBD), tetrahydrocannabinol (THC) or any combination of these or other cannabinoids.

"Our licence from Lexaria is what separates Biolog products from all others," said Biolog's chief executive Bruce Bauer.

"By incorporating the DehydraTECH drug delivery platform into our products, the bitterness and the earthy taste of cannabis oil are masked, and this technology ensures quick and effective transportation into the bloodstream without degradation in the stomach or liver."

Bauer noted that the cannabidiol (CBD) market was projected to reach $2.1 billion by 2020

Redfund chief executive Meris Kott added: "New delivery systems with patented technology have become extremely relevant in the cannabis medical arena.

"These cutting-edge discoveries will continue to make CBD and medical cannabis mainstream drugs in the very near futures. Biolog is a company on the cusp of greatness and Redfund is pleased they are an early-stage portfolio company."

Biolog, noted Redfund, is progressing rapidly in its research, intellectual property (IP) development and product expansion on its planned menu of product lines.

These lines are Cannastix, CannaTab and CannaPro protein powder.

Quick facts: Redfund Capital Corp.

Price: 0.06 CAD

Market: CSE
Market Cap: $3.4 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Redfund Capital Corp. named herein, including the promotion by the Company of Redfund Capital Corp. in any Content on the Site, the Company...



Redfund Capital partner Cannamerx International launches Hemp/CBD Auction...

Redfund Capital Corp (CSE:LOAN) (OTCMKTS:PNNRF) CEO Meris Kott tells Proactive Investors the cannabis-focused financier has formed a strategic alliance with hemp-auction platform Cannabis Mercantile Exchange that launches today. Kott says Redfund will help with financing and building...

on 21/3/19

2 min read